Genetic Basis of Carbamazepine Hypersensitivity

J Gordon Millichap

doi:10.15844/pedneurbriefs-15-5-2

Genetic Basis of Carbamazepine Hypersensitivity

Pediatric Neurology Briefs

Volume 15 (2001): Issue 5

By: J Gordon Millichap

Open Access

|May 2001

Abstract

The genetic basis of carbamazepine hypersensitivity was investigated in 60 affected patients (37 with mild rashes and 23 severe reactions) and 63 control non-sensitive subjects taking carbamazepine and treated at the University of Liverpool, UK.

References

Pirmohamed M Lin K Chadwick D Park BK TNFalpha promoter region gene polymorphisms in carbamazepine-hypersensitive patients Neurology 2001 Apr 10 56 7 890 6 10.1212/WNL.56.7.890 11294926
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-15-5-2 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 34 - 34

Published on: May 1, 2001

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Major Histocompatibility Complex,

Immune Etiology,

Stevens-Johnson Syndrome

© 2001 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 15 (2001): Issue 5